… malignancy, poor prognosis, and drug resistance. Recent studies have demonstrated that
GAS5 can … In addition, GAS5 participates in regulating proliferation, invasion, and apoptosis …

… the down-regulation of GAS5 led to the rescue of primary and malignant T-lymphocytes from
… GAS5 inhibits cell proliferation also through the miR-544/RUNX3 pathway [102], where it …

… GAS5 is downregulated in a number of human malignancies. GAS5 can induce apoptosis
and inhibit the proliferative and metastatic properties of tumors. The exact molecular …

… In summary, lncRNA GAS5 was a prognostic biomarker of disease free survival in BTCC …
inhibit malignant proliferation and resistance to doxorubicin in BTCC cells. LncRNA GAS5 might …

… was demonstrated to decrease gastric cancer cell proliferation and … GAS5 could promote
cell proliferation. Finally, we found that GAS5 could influence gastric cancer cells proliferation, …

… The low level of GAS5 expression often elevates capacity of proliferation and predicts …
Prostate cancer is the most prevalent malignancy in male patients. Mouse xenograft models …

… that GAS5 levels modify cell proliferation in vitro, and that GAS5 expression in MPM tissue
is associated with cell quiescence and podoplanin expression support a role of GAS5 in MPM …

… Moreover, overexpression of GAS5 was demonstrated to suppress ovarian … cell proliferation
in vitro and in vivo. Finally, we found that GAS5 influenced ovarian cancer cell proliferation, …

… Aberrant expression of GAS5 promotes cancer cell proliferation and suppresses apoptosis
via different downstream signaling molecules in a variety of malignancy. Taken together, …

… of GAS5 inhibited cell proliferation and survival, and induced G0/G1 cell cycle arrest and
apoptosis; however, knockdown of GAS5 expression enhanced cell proliferation, … that GAS5 is …